Bruinsma, R.S.; de Leng, W.W.J.; Fiocco, M.F.; Dierselhuis, M.P.; Langenberg, K.P.; Molenaar, J.J.; Kester, L.A.; van Noesel, M.M.; Tytgat, G.A.M.; van de Ven, C.P.;
et al. Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk. Cancers 2026, 18, 235.
https://doi.org/10.3390/cancers18020235
AMA Style
Bruinsma RS, de Leng WWJ, Fiocco MF, Dierselhuis MP, Langenberg KP, Molenaar JJ, Kester LA, van Noesel MM, Tytgat GAM, van de Ven CP,
et al. Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk. Cancers. 2026; 18(2):235.
https://doi.org/10.3390/cancers18020235
Chicago/Turabian Style
Bruinsma, Rixt S., Wendy W. J. de Leng, Marta F. Fiocco, Miranda P. Dierselhuis, Karin P. Langenberg, Jan J. Molenaar, Lennart A. Kester, Max M. van Noesel, Godelieve A. M. Tytgat, Cornelis P. van de Ven,
and et al. 2026. "Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk" Cancers 18, no. 2: 235.
https://doi.org/10.3390/cancers18020235
APA Style
Bruinsma, R. S., de Leng, W. W. J., Fiocco, M. F., Dierselhuis, M. P., Langenberg, K. P., Molenaar, J. J., Kester, L. A., van Noesel, M. M., Tytgat, G. A. M., van de Ven, C. P., Wijnen, M. H. W. A., de Krijger, R. R., & Steeg, A. F. W. v. d.
(2026). Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk. Cancers, 18(2), 235.
https://doi.org/10.3390/cancers18020235
